<DOC>
	<DOCNO>NCT00851578</DOCNO>
	<brief_summary>The purpose study characterize performance WATCHMAN LAA Closure Device atrial fibrillation patient long term warfarin therapy contraindicate .</brief_summary>
	<brief_title>ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>18 year age old paroxysma , persistent , permanent nonvlavular atrial fibrillation contraindicate warfarin eligible clopidogrel , ticlopdine , heparin , aspirin CHADS score 1 great NYHA Class IV LAA obliteration Heart transplant LVEF le 30 % great 50 % carotid stenosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>AF</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>LAA occlusion</keyword>
</DOC>